A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers
Status:
Completed
Trial end date:
2018-02-17
Target enrollment:
Participant gender:
Summary
This is a single-Center, Randomised, 4-Period, Phase 1 Study to Evaluate the
Pharmacokinetics, Safety and Tolerability, and Effect of Food on Pharmacokinetics following
Single Doses of MIV-711 Capsule and Tablet Formulations in Healthy Volunteers